Antipsychotic regulation of hippocampal dopamine receptor messenger RNA expression

Biological Psychiatry

Volumn 42, Issue 3, 1997, Pages 155-164

  Ritter, Laura M ^a   Meador Woodruff, James H ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Antipsychotic; Dopamine receptor; Hippocamus; Hybridization; In situ; Schizophrenia

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; HIPPOCAMPUS; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSIS; RAT; RECEPTOR DOWN REGULATION; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN MAPPING; CLOZAPINE; CULTURE TECHNIQUES; GENE EXPRESSION; HALOPERIDOL; HIPPOCAMPUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RNA, MESSENGER; SYNAPTIC TRANSMISSION;

EID: 0030746614     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00186-8     Document Type: Article

References (59)

1. Akbarian S, Vinuela A, Kim JJ, Potkin SG, Bunney WE Jr, Jones EG (1993): Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry 50:178-187.
2. Akil M, Lewis DA (1993): The dopaminergic innervation of monkey entorhinal cortex. Cereb Cortex 3:533-550.
3. Altshuler LL, Casanova MF, Goldberg TE, Kleinmann JE (1990): The hippocampus and parahippocampus in schizophrenic suicide and control brains. Arch Gen Psychiatry 47:1029-1034.
4. 2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat. Mol Brain Res 11:161-166.
5. Arnold SE, Hyman BT, Van Hoesen GW, Damasio AR (1991a): Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 48:625-632.
6. Arnold SE, Lee VM, Gur RE, Trojanowski JQ (1991b): Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci USA 88: 10850-10854.
7. Baskys A, Wang S, Remington G, Wojtowicz JM (1993): Haloperidol and loxapine but not clozapine increase synaptic responses in the hippocampus. Eur J Pharmacol 235:305-307.
8. 2 receptor mRNA in response to haloperidol treatment: A quantitative in situ hybridization study. Neuroscience 45:117-126.
9. Bischoff S (1981): Increase in in vivo (3H) spiperone binding in the rat hippocampal formation and striatum after repeated treatment with haloperidol. Experientia 37:1008-1009.
10. 2 receptors are unevenly distributed in the rat hippocampus and are modulated differently than in striatum. Eur J Pharmacol 245:157-164.
11. Burt DR, Creese I, Snyder SH (1977): Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain. Science 196:326-328.
12. 2 receptors in the brain of several mammalian species. J Neural Transm Gen Sect 80:105-127.
13. 2 dopamine binding site up regulation and apomorphine-induced stereotypy. Pharmacol Biochem Behav 28:477-482.
14. 2 receptor mRNA after lesions of haloperidol treatment. Eur J Pharmacol 186:369-371.
15. 1 sites. Neuroscience 28:263-273.
16. 2 dopamine receptor mRNAs: Ontogenetic and pharmacological studies. Neurochem Int 20(suppl):45S-48S.
17. Damask SP, Bovenkerk KA, de la Pena G, Hoversten KM, Peters DB, Valentine AM, et al (1996): Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex. Mol Brain Res 41:241-249.
18. 1 dopamine receptors in the rat brain: A quantitative autoradiographic analysis. J Neurosci 6:2352-2365.
19. 1 receptor. Nature 347:72-75.
20. Falkai P, Bogerts B, Rozumek M (1988): Limbic pathology in schizophrenia: Entorhinal region - A morphometric study. Biol Psychiatry 24:515-521.
21. Fallon JH, Koziell DA, Moore RY (1978): Catecholamine innervation of the basal forebrain: II. Amygdala, suprarhinal cortex and entorhinal cortex. J Comp Neurol 180:509-532.
22. Fox CA, Mansour A, Watson SJ Jr (1994): The effects of haloperidol on dopamine receptor gene expression. Exp Neurol 130:288-303.
23. Gaspar P, Berger B, Febvret A, Vigny A, Henry JD (1989): Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-betahydroxylase. J Comp Neurol 279:249-271.
24. Giros B, Martres M-P, Sokoloff P, Schwartz J-C (1990): Clonage du gene du recepteur dopaminergique D3 humain et identification de son chromosome. Acad Sci Paris 311:501-508.
25. Goldsmith SK, Joyce JN (1994): Dopamine D2 receptor expression in hippocampus and parahippocampal cortex of rat, cat, and human in relation to tyrosine hydroxylase-immunoreactive fibers. Hippocampus 4:354-373.
26. Graham SR, Kokkinidis L (1993): Clozapine inhibits limbic system kindling: Implications for antipsychotic action. Mol Brain Res 30:597-605.
27. Grandy DK, Marchionni MA, Makam H, Stofko RE, Alfano M, Frothingham L, et al (1989): Cloning of the cDNA and gene for a human D2 dopamine receptor. Proc Natl Acad Sci USA 86:9762-9766.
28. 5 dopamine receptor genes: A functional receptor and two pseudogenes. Proc Natl Acad Sci USA 88:9175-9179.
29. Gruzelier J, et al (1988): Impairments on neuropsychologic tests of temporohippocampal and frontohippocampal functions and word fluency in remitting schizophrenia and affective disorders. Arch Gen Psychiatry 45:623-629.
30. Gur RE, Jaggi JL, Shtasel DL, Ragland JD, Gur RC (1994): Cerebral blood flow in schizophrenia: Effects of memory processing on regional activity. Biol Psychiatry 35:3-15.
31. Heckers S, Heinsen H, Heinsen YC, Beckmann H (1990): Limbic structures and lateral ventricle in schizophrenia. Arch Gen Psychiatry 47:1016-1022.
32. Joyce JN (1993): The dopamine hypothesis of schizophrenia: Limbic interactions with serotonin and norepinephrine. Psychopharmacology 112(suppl 1):S16-S34.
33. 2 receptors in basal ganglia and cortex of human brain. J Pharmacol Exp Ther 257:1253-1263.
34. 2 receptors in rat hippocampal region. Neurosci Lett 125:107-109.
35. Krieckhaus EE, Donahoe JW, Morgan MA (1992): Paranoid schizophrenia may be caused by dopamine hyperactivity of CA1 hippocampus. Biol Psychiatry 31:560-570.
36. Le Moine C, Normand E, Guitteny AF, Fouque B, Teoule R, Bloch B (1990): Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc Natl Acad Sci USA 87:230-234.
37. 2 dopamine receptors in the medial prefrontal cortex of the rat. Psychopharmacology (Berl) 95:255-257.
38. 2 receptor isoforms in various cerebral tissues. J Neurochem 58:673-679.
39. 2-receptor mRNA level in rat striatum after chronic haloperidol treatment. Neurosci Res 12:440-445.
40. Meador-Woodruff, JH (1994): Update on dopamine receptors. Ann Clin Psychiatry 6:79-90.
41. Meador-Woodruff JH (1995): Neuroanatomy of dopamine receptor gene expression: Potential substrates for neuropsychiatric illness. Clin Neuropharmacol 18(suppl 1):S14-S24.
42. 2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology 5:231-242.
43. Meador-Woodruff JH, Damask SP, Watson SJ Jr (1994a): Differential expression of autoreceptors in the ascending dopamine systems of the human brain. Proc Natl Acad Sci USA 91:8297-8301.
44. Meador-Woodruff JH, Grandy DK, Van Tol HHM, Damask SP, Little KY, Civelli O, et al (1994b): Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology 10:239-247.
45. Milner TA, Bacon CE (1989): Ultrastructural localization of tyrosine hydroxylase-like immunoreactivity in the rat hippocampal formation. J Comp Neurol 281:479-495.
46. Samson Y, Wu JJ, Friedman AH, Davi JN (1990): Catecholaminergic innervation of the hippocampus in the cynomolgus monkey. J Comp Neurol 298:250-263.
47. 4 receptors by 2-fold in rats. Eur J Pharmacol 289:67-72.
48. 2 receptor mRNAs in rat brain. J Mol Neurosci 2:155-161.
49. 1. Nature 350:614-619.
50. 1 receptor encoded by an intronless gene on chromosome 5. Nature 347:80-83.
51. Tamminga CA, Thaker GK, Buchanan R, Kerkpatrick B, Alphs LD, Chase TN, et al (1992): Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 49:522-530.
52. Torack RM, Morris JC (1990): Tyrosine hydroxylase-like (TH) immunoreactivity in human mesolimbic system. Neurosci Lett 116:75-80.
53. Vahabzadeh A, Fillenz M (1992): Studies on the origin of rat hippocampal dihydroxyphenylacetic acid using microdialysis. Neurosci Lett 136:51-55.
54. 2 dopamine receptor mRNA level. Neurosci Lett 111:303-308.
55. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610-614.
56. Verhage M, Ghijsen WE, Boomsma F, Lopes da Silva FH (1992): Endogenous noradrenaline and dopamine in nerve terminals of the hippocampus: Differences in levels and release kinetics. J Neurochem 59:881-887.
57. 2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment. Life Sci 50:383-396.
58. 3H]YM-09151-2 in rat hippocampus: Characterization and autoradiographic distribution. Brain Res 681:153-159.
59. 1 dopamine receptors. Nature 347:76-79.